In summary, we evaluated an inhibitory antibody against MMP-9 as adjunctive treatment in combination with standard TB treatments in M. tuberculosis-infected C3HeB/FeJ mice, which develop well-organized, hypoxic TB granulomas as well as cavitary lesions after aerosol infection. The gene discussed is MMP9; the disease is Granuloma.